Logo Image

Shorts

Why Residual Cancer Burden is a Game-Changer for Oncology
0:33
Why Residual Cancer Burden is a Game-Changer for Oncology
2 months ago
by
Lajos Pusztai, MD, PhD
Treating High-Risk CLL: Balancing Efficacy and Duration
0:40
Treating High-Risk CLL: Balancing Efficacy and Duration
2 months ago
by
Nicole Lamanna, MD
Why BRAF Testing Is Critical in ATC
0:35
Why BRAF Testing Is Critical in ATC
2 months ago
by
Nabil Saba, MD
Rare but Targetable: Advances in Biliary Tract Cancer
0:47
Rare but Targetable: Advances in Biliary Tract Cancer
2 months ago
by
Linda Y. Wu, MD
The Sequencing Dilemma in Thyroid Cancer
0:37
The Sequencing Dilemma in Thyroid Cancer
2 months ago
by
Nabil Saba, MD
Future-Proofing Treatment in Younger Patients With CLL
1:04
Future-Proofing Treatment in Younger Patients With CLL
2 months ago
by
Nicole Lamanna, MD
Tackling Resistance in Pancreatic Cancer
0:48
Tackling Resistance in Pancreatic Cancer
2 months ago
by
Linda Y. Wu, MD
Patient Preference: The Heart of CLL Treatment Decisions
0:36
Patient Preference: The Heart of CLL Treatment Decisions
2 months ago
by
Nicole Lamanna, MD
Why Every Thyroid Cancer Patient Needs Genomic Analysis
0:43
Why Every Thyroid Cancer Patient Needs Genomic Analysis
2 months ago
What is the Role of PCI in LS-SCLC?
0:41
What is the Role of PCI in LS-SCLC?
2 months ago
by
Raj Singh, MD
Combining KRAS Inhibition With Immunotherapy in NSCLC
1:01
Combining KRAS Inhibition With Immunotherapy in NSCLC
3 months ago
by
Jamie E. Chaft, MD
Evolving Clinical Utility of ctDNA in Upper GI Cancer Care
0:54
Evolving Clinical Utility of ctDNA in Upper GI Cancer Care
3 months ago
by
Ryan H. Moy, MD, PhD
Dr Raj Singh on Advances in Head and Neck Cancer Therapy
0:36
Dr Raj Singh on Advances in Head and Neck Cancer Therapy
3 months ago
by
Raj Singh, MD
Unlocking the Secrets of Breast Cancer Mutations
0:46
Unlocking the Secrets of Breast Cancer Mutations
3 months ago
by
Pedram Razavi, MD, PhD
The Huge Unmet Need: CNS Efficacy in Lung Cancer Drugs
1:05
The Huge Unmet Need: CNS Efficacy in Lung Cancer Drugs
3 months ago
by
Helena Yu, MD
The Danger of Relying Solely on Negative ctDNA Tests
0:49
The Danger of Relying Solely on Negative ctDNA Tests
3 months ago
by
Catherine T. Haring, MD
Can Myeloma Treatment Be Done at Home?
0:57
Can Myeloma Treatment Be Done at Home?
3 months ago
by
Sikander Ailawadhi, MD
MRD Alerts: How Soon Will Imaging Confirm Progression?
0:34
MRD Alerts: How Soon Will Imaging Confirm Progression?
3 months ago
by
Rutika Mehta, MD, MPH
The Future of Targeted Therapy in Mesothelioma
0:33
The Future of Targeted Therapy in Mesothelioma
3 months ago
by
Michael Offin, MD
Dr Kittai on The Role of MRD Testing in CLL
0:39
Dr Kittai on The Role of MRD Testing in CLL
3 months ago
by
Adam Kittai, MD(+1 more)
How Proton Therapy is Revolutionizing Cancer Treatment
0:33
How Proton Therapy is Revolutionizing Cancer Treatment
3 months ago
by
Charles Simone, MD
Why Patient Preference Matters in CLL Treatment
0:41
Why Patient Preference Matters in CLL Treatment
3 months ago
by
Adam Kittai, MD(+1 more)
Low ctDNA May Signal Aggressive Tumor in Head and Neck Cancer
1:00
Low ctDNA May Signal Aggressive Tumor in Head and Neck Cancer
3 months ago
by
Catherine T. Haring, MD
The Biggest Unmet Needs in Lung Cancer
1:03
The Biggest Unmet Needs in Lung Cancer
3 months ago
by
Adam Schoenfeld, MD
Talking MRD and ctDNA With Patients
0:34
Talking MRD and ctDNA With Patients
3 months ago
by
Rutika Mehta, MD, MPH
Who Should Get Neoadjuvant Therapy in RCC
0:30
Who Should Get Neoadjuvant Therapy in RCC
3 months ago
by
Naomi Haas, MD
Don't Believe The Google Prognosis: New Hope For Glioblastoma
0:30
Don't Believe The Google Prognosis: New Hope For Glioblastoma
3 months ago
by
Chibawanye Ene, MD, PhD
Why We Need To Look Outside the Brain to Treat Tumors
0:32
Why We Need To Look Outside the Brain to Treat Tumors
3 months ago
by
Chibawanye Ene, MD, PhD
Adjuvant Therapy in Non-Clear Cell RCC
0:44
Adjuvant Therapy in Non-Clear Cell RCC
3 months ago
by
Naomi Haas, MD
The Prognostic Potential of MRD/ctDNA in Metastatic GE Cancer
0:52
The Prognostic Potential of MRD/ctDNA in Metastatic GE Cancer
3 months ago
by
Rutika Mehta, MD, MPH